tyrosine has been researched along with pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badr, A; Kimura, H; Meguro, T; Zhang, JH | 1 |
Crooke, A; Guzmán-Aránguez, A; Pintor, J; Yayon, A | 1 |
2 other study(ies) available for tyrosine and pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid
Article | Year |
---|---|
Suramin-induced reversal of chronic cerebral vasospasm in experimental subarachnoid hemorrhage.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Chronic Disease; Dogs; Female; Male; Oxyhemoglobins; Phosphorylation; Platelet Aggregation Inhibitors; Protein-Tyrosine Kinases; Pyridoxal Phosphate; Receptors, Purinergic P2; Subarachnoid Hemorrhage; Suramin; Tyrosine; Vasospasm, Intracranial | 2002 |
Effect of PPADS on achondroplasic chondrocytes: inhibition of FGF receptor type 3 over-activity.
Topics: Achondroplasia; Animals; Cell Line; Cell Survival; Chondrocytes; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Matrix; Fibroblast Growth Factor 9; Humans; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Phosphorylation; Protein Kinase Inhibitors; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Purinergic P2; Signal Transduction; Time Factors; Transfection; Tyrosine | 2008 |